Sahebi Leyla, Ansarin Khalil, Mohajeri Parviz, Khalili Majid, Monfaredan Amir, Farajnia Safar, Zadeh Simin Khayyat
Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Science. Tabriz, Iran.
Microbiology Department, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Open Respir Med J. 2016 Jun 30;10:29-35. doi: 10.2174/1874306401610010029. eCollection 2016.
Tuberculosis (TB) is the leading cause of morbidity and mortality among chronic infectious diseases.
The goal of this cross-sectional study (2011-2013;2013) was to examine the patterns of TB drug resistance among HIV-negative pulmonary TB patients in regions near the Iranian border.
To this end, MTB isolates were harvested from 300 HIV-negative, pulmonary smear-positive TB patients from the northwest and west Iranian border provinces. Isolates were subjected to first and second-line drug susceptibility testing by the 1% proportion method. Demographic and clinical data were provided using a questionnaire and information from patient records. Results were analyzed using SPSS-18.
The mean age of the patients was 52.03 years and 54.3% were male. The prevalence of resistance to any TB drug was 13.6% (38 cases). Eleven percent of the new treatment TB group (28 patients) and 40.7% of the retreatment TB group (11 patients) were resistant to all TB drugs. Twelve (4.3%) patients had multidrug-resistant tuberculosis (MDR-TB) (2.38% in the new TB treatment group and 23.1% in the retreatment group). One patient had extensively drug-resistant tuberculosis (XDR-TB). There was a statistically significant relationship between TB drug resistance and smoking (p=0.02) and a history of migration from village to city (p=0.04), also between TB drug resistance and recurrence of TB in patients that had previously received treatment (p<0.001).
Knowledge of drug resistance patterns for new and previously treated cases is critical for effective control of MDR-TB in different regions of the country. The burden of MDR-TB in retreatment cases was high. Previous TB treatment was one of the most important mokers and those who had a history of rural to urban migration were at high risk for the occurrence of TB drug resistance.
结核病是慢性传染病中发病和死亡的主要原因。
这项横断面研究(2011 - 2013年;2013年)的目的是调查伊朗边境附近地区HIV阴性肺结核患者的结核耐药模式。
为此,从伊朗西北部和西部边境省份的300例HIV阴性、痰涂片阳性肺结核患者中采集结核分枝杆菌分离株。采用1%比例法对分离株进行一线和二线药物敏感性检测。通过问卷调查和患者病历信息提供人口统计学和临床数据。使用SPSS - 18进行结果分析。
患者的平均年龄为52.03岁,54.3%为男性。对任何一种抗结核药物耐药的患病率为13.6%(38例)。新治疗肺结核组的11%(28例患者)和复治肺结核组的40.7%(11例患者)对所有抗结核药物耐药。12例(4.3%)患者患有耐多药结核病(MDR - TB)(新肺结核治疗组为2.38%,复治组为23.1%)。1例患者患有广泛耐药结核病(XDR - TB)。结核耐药与吸烟(p = 0.02)、从农村迁移到城市的病史(p = 0.04)之间存在统计学显著关系,在既往接受过治疗的患者中,结核耐药与结核病复发之间也存在统计学显著关系(p < 0.001)。
了解新发病例和既往治疗病例的耐药模式对于有效控制该国不同地区的耐多药结核病至关重要。复治病例中耐多药结核病的负担较高。既往结核病治疗是最重要的危险因素之一,有从农村到城市迁移病史的人发生结核耐药的风险较高。